1,009
Views
1
CrossRef citations to date
0
Altmetric
CAMDA 2014

An integrative exploratory analysis of –omics data from the ICGC cancer genomes lung adenocarcinoma study

, , , , , & show all
Pages 54-62 | Received 03 Oct 2014, Accepted 08 Apr 2015, Published online: 21 May 2015

References

  • Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009; 458:719-24; PMID:19360079; http://dx.doi.org/10.1038/nature07943.
  • Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland A, et al. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proc Natl Acad Sci U S A 2012; 109:2802-7; PMID:21908711; http://dx.doi.org/10.1073/pnas.1108781108.
  • Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Statistical Society B 2005; 67:301-20; http://dx.doi.org/10.1111/j.1467-9868.2005.00503.x.
  • Guillot L, Epaud R, Thouvenin G, Jonard L, Mohsni A, Couderc R, Counil F, de Blic J, Taam RA, Le Bourgeois M, et al. New surfactant protein C gene mutations associated with diffuse lung disease. J Med Genet 2009; 46:490-4; http://dx.doi.org/10.1136/jmg.2009.066829.
  • Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344:573-9; http://dx.doi.org/10.1056/NEJM200102223440805.
  • Thomas AQ, Lane K, Phillips III J, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165:1322-8; PMID:11991887; http://dx.doi.org/10.1164/rccm.200112-123OC.
  • Jiang F, Caraway NP, Bekele BN, Zhang HZ, Khanna A, Wang H, Li R, Fernandez RL, Zaidi TM, Johnston DA, et al. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Clin Cancer Res 2005; 11:5417-24; PMID:16061856; http://dx.doi.org/10.1158/1078-0432.CCR-04-2087.
  • Lüfgren J, Rämet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002; 185:283-9.
  • Pettigrew MM, Gent JF, Zhu Y, Triche EW, Belanger KD, Holford TR, Bracken MB, Leaderer BP. Association of surfactant protein A polymorphisms with otitis media in infants at risk for asthma. BMC Med Genet 2006; 7:68; http://dx.doi.org/10.1186/1471-2350-7-68.
  • Pettigrew MM, Gent JF, Zhu Y, Triche EW, Belanger KD, Holford TR, Bracken MB, Leaderer BP. Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes. BMC Med Genet 2007; 8:15; PMID:17407567; http://dx.doi.org/10.1186/1471-2350-8-15.
  • Seifart C, Lin HM, Seifart U, Plagens A, DiAngelo S, von Wichert P, Floros J. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma. Clin Genet 2005; 68:128-36; PMID:15996209; http://dx.doi.org/10.1111/j.1399-0004.2005.00470.x.
  • Stoffers M, Goldmann T, Branscheid D, Galle J, Vollmer E. Transcriptional activity of surfactant-apoproteins A1 and A2 in non-small cell lung carcinomas and tumor-free lung tissues. Pneumologie 2004; 58:395-9; PMID:15216431; http://dx.doi.org/10.1055/s-2004-818506.
  • Stray-Pedersen A, Vege A, Opdal SH, Moberg S, Rognum TO. Surfactant protein A and D gene polymorphisms and protein expression in victims of sudden infant death. Acta Paediatr 2009; 98:62-8; PMID:18983439; http://dx.doi.org/10.1111/j.1651-2227.2008.01090.x.
  • Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. MiRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27:2128-36; PMID:17968323; http://dx.doi.org/10.1038/sj.onc.1210856.
  • Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X, Tang H. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19:828-37; PMID:19546886; http://dx.doi.org/10.1038/cr.2009.72.
  • Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647-58; PMID:17681183; http://dx.doi.org/10.1053/j.gastro.2007.05.022.
  • Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68:8164-72; PMID:18829576; http://dx.doi.org/10.1158/0008-5472.CAN-08-1305.
  • Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM. Estradiol down regulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 2009; 37:2584-95; PMID:19264808; http://dx.doi.org/10.1093/nar/gkp117.
  • Zheng J, Xue H, Wang T, Jiang Y, Liu B, Li J, Liu Y, Wang W, Zhang B, Sun M. miR-21 downregulates the tumor suppressor P12 CDK2AP1 and Stimulates Cell Proliferation and Invasion. J Cell Biochem 2011; 112:872-80; PMID:21328460; http://dx.doi.org/10.1002/jcb.22995.
  • Han S, Khuri FR, Roman J. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res 2006; 66:315-23; PMID:16397245; http://dx.doi.org/10.1158/0008-5472.CAN-05-2367.
  • Oxnard GR, Binder A, Jänne PA. New targetable oncogenes in non-small-cell lung cancer. J Clin Oncol 2013; 31:1097-104; PMID:23401445; http://dx.doi.org/10.1200/JCO.2012.42.9829.
  • Liu W-b, Jiang X, Han F, Li Y-h, Chen H-q, Liu Y, Cao J, Liu J-y. LHX6 acts as a novel potential tumor suppressor with epigenetic inactivation in lung cancer. Cell Death Dis 2013; 4:e882; http://dx.doi.org/10.1038/cddis.2013.366.
  • Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002; 21:5450-61; PMID:12154407; http://dx.doi.org/10.1038/sj.onc.1205605.
  • Brock G, Pihur V, Datta S, Datta S. clValid: An R package for cluster validation. J Statistical Software 2008; 25:1-22.
  • Datta S, Datta S. Comparisons and validation of statistical clustering techniques for microarray gene expression data. Bioinformatics 2003; 19:459-66; PMID:12611800; http://dx.doi.org/10.1093/bioinformatics/btg025.
  • Pihur V, Datta S, Datta S. Weighted rank aggregation of cluster validation measures: a Monte Carlo cross-entropy approach. Bioinformatics 2007; 23:1607-15; http://dx.doi.org/10.1093/bioinformatics/btm158.
  • Pihur V, Datta S, Datta S. RankAggreg, an R package for weighted rank aggregation. BMC Bioinformatics 2009; 10:62; PMID:19228411; http://dx.doi.org/10.1186/1471-2105-10-62.
  • Datta S, Pihur V, Datta S. An adaptive optimal ensemble classifier via bagging and rank aggregation with applications to high dimensional data. BMC Bioinformatics 2010; 11:427; http://dx.doi.org/10.1186/1471-2105-11-427.
  • Shah JS, Datta S, Datta S. A multi-loss super regression learner via bagging and rank aggregation with application to survival prediction using proteomics. Computational Statistics 2014; 29:1749-67; PMID:20716381; http://dx.doi.org/10.1007/s00180-014-0516-z.
  • Blain SW, Scher HI, Cordon-Cardo C, Koff A. p27 as a target for cancer therapeutics. Cancer Cell 2003; 3:111-5; PMID:12620406; http://dx.doi.org/10.1016/S1535-6108(03)00026-6.
  • Baik CS, Eaton KD. Estrogen signaling in lung cancer: an opportunity for novel therapy. Cancers 2012; 4:969-88; PMID:24213497; http://dx.doi.org/10.3390/cancers4040969.
  • Pawlak G, McGarvey TW, Nguyen TB, Tomaszewski JE, Puthiyaveettil R, Malkowicz SB, Helfman DM. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer 2004; 110:368-73; http://dx.doi.org/10.1002/ijc.20151.
  • www.genecards.org/cgi-bin/carddisp.pl?gene=ESR1.
  • Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E, et al. CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res 2010; 30:3093-8.
  • Chang BL, Zheng SL, Isaacs SD, Wiley KE, Turner A, Li G, Walsh PC, Meyers DA, Isaacs WB, Xu J. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. Cancer Res 2004; 64:1997-9; http://dx.doi.org/10.1158/0008-5472.CAN-03-2340.
  • Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, Cerroni L. Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol 2010; 130:1152-7; http://dx.doi.org/10.1038/jid.2009.369.
  • Charlesworth A, Chiaverini C, Chevrant-Breton J, DelRio M, Diociaiuti A, Dupuis RP, El Hachem M, Le Fiblec B, Sankari-Ho AM, Valhquist A, et al. Epidermolysis bullosa simplex with PLEC mutations: new phenotypes and new mutations. Br J Dermatol 2013; 168:808-14; PMID:23289980; http://dx.doi.org/10.1111/bjd.12202.
  • Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majen M, Lopez-Vivanco G, Isla D, Provencio M, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009; 361:958-67; PMID:19692684; http://dx.doi.org/10.1056/NEJMoa0904554.
  • Handl J, Knowles J, Kell DB. Computational cluster validation in post-genomic data analysis. Bioinformatics 2005; 21:3201-12; PMID:15914541; http://dx.doi.org/10.1093/bioinformatics/bti517.
  • Rousseeuw PJ. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Computat Appl Math 1987; 20:53-65; http://dx.doi.org/10.1016/0377-0427(87)90125-7.
  • Dunn JC. Well-separated clusters and optimal fuzzy partitions. J Cybernet 1974; 4:95-104; http://dx.doi.org/10.1080/01969727408546059.
  • Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Statist Software 2010; 33:1-22; PMID:20808728.
  • Efron B, Tibshirani R. Improvements on cross-validation: the 632+ bootstrap method. J Am Statist Associat 1997; 92:548-60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.